Recently, accumulating evidence reported that pretreatment of MSCs with adipokines including Asprosin and C1q/tumor necrosis factor-related protein-9 remarkably enhanced MSC survival in the ischemic microenvironment, thereby improving the therapeutic effects of MSCs in MI [35, 36]. Here, FBN1 is linked to myocardial infarction.